Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
RTC Research & Development, officially known as Research and Toxicology Centre (RTC) S.p.A., is a leading Italian contract research organization (CRO) specializing in non-clinical safety assessment and toxicology. Founded in 1972 and headquartered in Pomezia, Italy, the company provides a comprehensive suite of services including general toxicology, genetic toxicology, reproductive toxicology, and safety pharmacology. RTC serves the pharmaceutical, biotech, chemical, and agrochemical industries, ensuring regulatory compliance for new product development. In 2014, the company was acquired by Eurofins Scientific, integrating its expertise into Eurofins' global BioPharma services network. The facility is GLP-compliant and recognized by international regulatory authorities such as the FDA and EMA.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on RTC Research & Development.